FDA 483 - Unisis Corp. - May 18, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Unisis Corp., a medical device manufacturer in Koshigaya, Saitama, Japan, received a Form FDA 483 with five observations during an inspection from May 15-18, 2023. The inspection revealed significant deficiencies in the firm's quality system, including a lack of established procedures for design control, corrective and preventive actions, in-process product acceptance, and purchasing controls. Additionally, the firm failed to ensure device history records conformed to master records and did not require contract manufacturers to be registered or listed with the U.S. FDA.
ID · 5b7bb121-9ce5-4c1b-a8c2-1c33de8ffae1